1. Hubertus Haas  Is a corresponding author
  1. Medical University of Innsbruck, Austria

Fungi affect our lives in many different ways, both positive and negative. One of the reasons for this is that most fungi produce a multitude of small organic molecules called secondary metabolites. Different species employ a strikingly diverse arsenal of secondary metabolites, most of which are released into the environment (Sanchez et al., 2012). Secondary metabolites are not directly required to ensure the growth of the organism, but confer an advantage under specific environmental conditions.

Fungi use secondary metabolites to defend against predators and competitors, for chemical communication, or in the case of pathogenic fungi, to manipulate their animal and plant hosts (Brakhage et al., 2013). Secondary metabolism is therefore likely to be shaped to a large extent by interactions with other organisms. For example, fungi secrete enzymes to digest their food, which allows them to grow on virtually any organic matter, but also means that the products of their digestion are in principle a free meal for other organisms. And by secreting secondary metabolites that target these organisms, fungi are able to defend their niche to avoid competitors taking advantage of the available food.

Well-known examples of secondary metabolites produced by fungi are the poisonous food contaminant aflatoxin, the antibiotic penicillin and the anticancer drug taxol. These molecules illustrate the negative and positive effects of secondary metabolites on humans, and underline their outstanding potential for medicinal use. However, it is not known what roles most of these molecules play in the lives of the fungi that produce them. Moreover, most secondary metabolites are not produced when the fungi are grown in the laboratory, which makes it difficult to characterize them. Now in eLife, Matthias Brock and co-workers – including Markus Gressler as first author – report a new role for a major secondary metabolite called terrein, and characterize the environmental stimuli that induce the mold Aspergillus terreus to produce it (Figure 1; Gressler et al., 2015).

Environmental signals activate production of terrein by the mold Aspergillus terreus to improve its competitiveness.

To adapt to changing environmental conditions and different ecological niches, microorganisms need to be able to sense and respond to environmental signals. Gressler et al. identified three independent signals that stimulate production of the compound terrein by Aspergillus terreus – nitrogen starvation, methionine, and iron starvation. In this mold's natural niche within plants and in the soil surrounding plant roots, terrein is a chemical weapon used to inhibit the growth of bacteria, plants and other fungi, but also helps to improve iron supply to the producer.

A. terreus is a common soil-borne fungus that feeds on dead organic material, but is also able to invade plants and cause life-threatening infections in humans with weakened immune systems. Genome analysis indicated that this fungus might produce more than 68 secondary metabolites, although only 14—including the cholesterol-lowering drug lovastatin—have been identified so far (Guo and Wang, 2014). The compound terrein was first described 80 years ago, but how A. terreus makes terrein was only resolved in 2014 by the Brock group (Zaehle et al., 2014). Terrein was previously shown to be harmful to plant cells as it inhibits the germination of seeds and causes lesions on plant surfaces, and probably helps the fungus to colonize its host.

Based on the observation that potato extract (an ingredient of a standard medium used for culturing fungi) activates the production of terrein, Gressler et al. – who are based at the Hans Knoell Institute, Friedrich Schiller University and Nottingham University – systematically characterized how different conditions impact terrein production. This analysis revealed that the genes that encode the terrein biosynthetic pathway are activated by three independent environmental stimuli: nitrogen starvation, iron starvation, and the presence of the amino acid methionine. These conditions are typically found in the plant and the plant root area, known as the rhizosphere, and are used by the mold to sense these niches.

Next, by genetic engineering of the mold, Gressler et al. identified three transcription factors that activate genes in response to environmental signals. Previous studies have revealed the roles of these regulators in altering the production of primary metabolites – which are required for normal growth and reproduction – in response to stress and the availability of nitrogen and iron (Haas, 2012; Tudzynski, 2014). However, it is not known how the mold perceives the methionine signal. Nitrogen and iron also regulate the production of other secondary metabolites (Tudzynski, 2014; Wiemann et al., 2014), suggesting that these environmental cues are often used to adjust secondary metabolism. The complex environmental control of terrein production revealed by Gressler et al. represents a prime example of how microorganisms adapt their secondary metabolism to the niche they inhabit.

In addition to its ability to inhibit the growth of plants, it has been reported that terrein can inhibit the growth of bacteria, fungi and mammalian cells, and that it can also act as an antioxidant and anti-inflammatory (Zaehle et al., 2014). Now, Gressler et al. have discovered that terrein supports iron uptake by the fungus that produces it, but inhibits the growth of even closely related molds. This clearly indicates that terrein improves the competiveness of the producer. It will be exciting to learn how terrein is able to influence many different biological processes in different organisms, and how the producer protects itself against this molecule.

References

Article and author information

Author details

  1. Hubertus Haas

    Division of Molecular Biology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria
    For correspondence
    hubertus.haas@i-med.ac.at
    Competing interests
    The author declares that no competing interests exist.

Publication history

  1. Version of Record published:

Copyright

© 2015, Haas

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,989
    views
  • 242
    downloads
  • 6
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Hubertus Haas
(2015)
Microbial Ecology: How to trigger a fungal weapon
eLife 4:e10504.
https://doi.org/10.7554/eLife.10504

Further reading

    1. Biochemistry and Chemical Biology
    2. Chromosomes and Gene Expression
    Kira A Cozzolino, Lynn Sanford ... Dylan J Taatjes
    Research Article

    Hyperactive interferon (IFN) signaling is a hallmark of Down syndrome (DS), a condition caused by Trisomy 21 (T21); strategies that normalize IFN signaling could benefit this population. Mediator-associated kinases CDK8 and CDK19 drive inflammatory responses through incompletely understood mechanisms. Using sibling-matched cell lines with/without T21, we investigated Mediator kinase function in the context of hyperactive IFN in DS over a 75 min to 24 hr timeframe. Activation of IFN-response genes was suppressed in cells treated with the CDK8/CDK19 inhibitor cortistatin A (CA), via rapid suppression of IFN-responsive transcription factor (TF) activity. We also discovered that CDK8/CDK19 affect splicing, a novel means by which Mediator kinases control gene expression. To further probe Mediator kinase function, we completed cytokine screens and metabolomics experiments. Cytokines are master regulators of inflammatory responses; by screening 105 different cytokine proteins, we show that Mediator kinases help drive IFN-dependent cytokine responses at least in part through transcriptional regulation of cytokine genes and receptors. Metabolomics revealed that Mediator kinase inhibition altered core metabolic pathways in cell type-specific ways, and broad upregulation of anti-inflammatory lipid mediators occurred specifically in kinase-inhibited cells during hyperactive IFNγ signaling. A subset of these lipids (e.g. oleamide, desmosterol) serve as ligands for nuclear receptors PPAR and LXR, and activation of these receptors occurred specifically during hyperactive IFN signaling in CA-treated cells, revealing mechanistic links between Mediator kinases, lipid metabolism, and nuclear receptor function. Collectively, our results establish CDK8/CDK19 as context-specific metabolic regulators, and reveal that these kinases control gene expression not only via TFs, but also through metabolic changes and splicing. Moreover, we establish that Mediator kinase inhibition antagonizes IFN signaling through transcriptional, metabolic, and cytokine responses, with implications for DS and other chronic inflammatory conditions.

    1. Biochemistry and Chemical Biology
    2. Cancer Biology
    Flavie Coquel, Sing-Zong Ho ... Philippe Pasero
    Research Article

    Cancer cells display high levels of oncogene-induced replication stress (RS) and rely on DNA damage checkpoint for viability. This feature is exploited by cancer therapies to either increase RS to unbearable levels or inhibit checkpoint kinases involved in the DNA damage response. Thus far, treatments that combine these two strategies have shown promise but also have severe adverse effects. To identify novel, better-tolerated anticancer combinations, we screened a collection of plant extracts and found two natural compounds from the plant, Psoralea corylifolia, that synergistically inhibit cancer cell proliferation. Bakuchiol inhibited DNA replication and activated the checkpoint kinase CHK1 by targeting DNA polymerases. Isobavachalcone interfered with DNA double-strand break repair by inhibiting the checkpoint kinase CHK2 and DNA end resection. The combination of bakuchiol and isobavachalcone synergistically inhibited cancer cell proliferation in vitro. Importantly, it also prevented tumor development in xenografted NOD/SCID mice. The synergistic effect of inhibiting DNA replication and CHK2 signaling identifies a vulnerability of cancer cells that might be exploited by using clinically approved inhibitors in novel combination therapies.